Day One Biopharmaceuticals, Inc. (DAWN) — Business segments and KPIs
Revenue by business segment and geography for Day One Biopharmaceuticals, Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Product | 155.42M | 98.3% |
| License | 2.76M | 1.7% |